Scientists say their new insights into how a key brain protein works could help resolve a long-standing question in molecular ...
Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU. Skyclarys ...
The registry is a contact list of individuals with cerebellar ataxia who are willing to be contacted for participation in research studies and clinical trials. When signing up, you will fill out some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results